268 related articles for article (PubMed ID: 28056358)
1. Administrations of human adult ischemia-tolerant mesenchymal stem cells and factors reduce amyloid beta pathology in a mouse model of Alzheimer's disease.
Harach T; Jammes F; Muller C; Duthilleul N; Cheatham V; Zufferey V; Cheatham D; Lukasheva YA; Lasser T; Bolmont T
Neurobiol Aging; 2017 Mar; 51():83-96. PubMed ID: 28056358
[TBL] [Abstract][Full Text] [Related]
2. Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model.
Kim KS; Kim HS; Park JM; Kim HW; Park MK; Lee HS; Lim DS; Lee TH; Chopp M; Moon J
Neurobiol Aging; 2013 Oct; 34(10):2408-20. PubMed ID: 23623603
[TBL] [Abstract][Full Text] [Related]
3. Intracerebral Injection of Extracellular Vesicles from Mesenchymal Stem Cells Exerts Reduced Aβ Plaque Burden in Early Stages of a Preclinical Model of Alzheimer's Disease.
Elia CA; Tamborini M; Rasile M; Desiato G; Marchetti S; Swuec P; Mazzitelli S; Clemente F; Anselmo A; Matteoli M; Malosio ML; Coco S
Cells; 2019 Sep; 8(9):. PubMed ID: 31510042
[TBL] [Abstract][Full Text] [Related]
4. Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer's disease.
Yang J; Kou J; Lalonde R; Fukuchi KI
Brain Behav Immun; 2017 Oct; 65():262-273. PubMed ID: 28526436
[TBL] [Abstract][Full Text] [Related]
5. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived mesenchymal stem cells contribute to the reduction of amyloid-β deposits and the improvement of synaptic transmission in a mouse model of pre-dementia Alzheimer's disease.
Bae JS; Jin HK; Lee JK; Richardson JC; Carter JE
Curr Alzheimer Res; 2013 Jun; 10(5):524-31. PubMed ID: 23036020
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell-derived extracellular vesicles ameliorate Alzheimer's disease-like phenotypes in a preclinical mouse model.
Cone AS; Yuan X; Sun L; Duke LC; Vreones MP; Carrier AN; Kenyon SM; Carver SR; Benthem SD; Stimmell AC; Moseley SC; Hike D; Grant SC; Wilber AA; Olcese JM; Meckes DG
Theranostics; 2021; 11(17):8129-8142. PubMed ID: 34373732
[TBL] [Abstract][Full Text] [Related]
8. Endogenous murine Aβ increases amyloid deposition in APP23 but not in APPPS1 transgenic mice.
Mahler J; Morales-Corraliza J; Stolz J; Skodras A; Radde R; Duma CC; Eisele YS; Mazzella MJ; Wong H; Klunk WE; Nilsson KPR; Staufenbiel M; Mathews PM; Jucker M; Wegenast-Braun BM
Neurobiol Aging; 2015 Jul; 36(7):2241-2247. PubMed ID: 25911278
[TBL] [Abstract][Full Text] [Related]
9. Intravenous administration of mesenchymal stem cells reduces Tau phosphorylation and inflammation in the 3xTg-AD mouse model of Alzheimer's disease.
Neves AF; Camargo C; Premer C; Hare JM; Baumel BS; Pinto M
Exp Neurol; 2021 Jul; 341():113706. PubMed ID: 33757765
[TBL] [Abstract][Full Text] [Related]
10. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
[TBL] [Abstract][Full Text] [Related]
11. Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models.
Zhao L; Gottesdiener AJ; Parmar M; Li M; Kaminsky SM; Chiuchiolo MJ; Sondhi D; Sullivan PM; Holtzman DM; Crystal RG; Paul SM
Neurobiol Aging; 2016 Aug; 44():159-172. PubMed ID: 27318144
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-induced Aβ-specific CD8+ T cells do not trigger autoimmune neuroinflammation in a murine model of Alzheimer's disease.
Rosset MB; Lui G; Dansokho C; Chaigneau T; Dorothée G
J Neuroinflammation; 2015 May; 12():95. PubMed ID: 25982697
[TBL] [Abstract][Full Text] [Related]
13. Intravenous infusion of monocytes isolated from 2-week-old mice enhances clearance of Beta-amyloid plaques in an Alzheimer mouse model.
Hohsfield LA; Humpel C
PLoS One; 2015; 10(4):e0121930. PubMed ID: 25830951
[TBL] [Abstract][Full Text] [Related]
14. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease.
van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF
Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007
[TBL] [Abstract][Full Text] [Related]
15. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
16. Reconstituted high-density lipoproteins acutely reduce soluble brain Aβ levels in symptomatic APP/PS1 mice.
Robert J; Stukas S; Button E; Cheng WH; Lee M; Fan J; Wilkinson A; Kulic I; Wright SD; Wellington CL
Biochim Biophys Acta; 2016 May; 1862(5):1027-36. PubMed ID: 26454209
[TBL] [Abstract][Full Text] [Related]
17. BDNF-producing, amyloid β-specific CD4 T cells as targeted drug-delivery vehicles in Alzheimer's disease.
Eremenko E; Mittal K; Berner O; Kamenetsky N; Nemirovsky A; Elyahu Y; Monsonego A
EBioMedicine; 2019 May; 43():424-434. PubMed ID: 31085101
[TBL] [Abstract][Full Text] [Related]
18. T-cell brain infiltration and immature antigen-presenting cells in transgenic models of Alzheimer's disease-like cerebral amyloidosis.
Ferretti MT; Merlini M; Späni C; Gericke C; Schweizer N; Enzmann G; Engelhardt B; Kulic L; Suter T; Nitsch RM
Brain Behav Immun; 2016 May; 54():211-225. PubMed ID: 26872418
[TBL] [Abstract][Full Text] [Related]
19. Feasibility and Efficacy of Intra-Arterial Administration of Embryonic Stem Cell Derived-Mesenchymal Stem Cells in Animal Model of Alzheimer's Disease.
Kim DY; Choi SH; Lee JS; Kim HJ; Kim HN; Lee JE; Shin JY; Lee PH
J Alzheimers Dis; 2020; 76(4):1281-1296. PubMed ID: 32597802
[TBL] [Abstract][Full Text] [Related]
20. Immunoproteasome deficiency alters microglial cytokine response and improves cognitive deficits in Alzheimer's disease-like APPPS1 mice.
Wagner LK; Gilling KE; Schormann E; Kloetzel PM; Heppner FL; Krüger E; Prokop S
Acta Neuropathol Commun; 2017 Jun; 5(1):52. PubMed ID: 28646899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
